The Devil in the Details - Chapter Two

Sharla Perrine Boehm earned a teaching degree from UCLA before channeling her talent for math into computer programming. While working at the Rand Corporation, she built a ground-breaking simulation, originally conceived to strengthen military communications during the Cold War. ...  Show more

“The only time I ever saw something that I thought was abnormal…there was a human arm in the refrigerator,” said J. Peter Willard about his aunt, Mary Louisa Willard. Otherwise, he insisted, she was “very normal.” But Mary Louisa Willard, a chemistry professor at Pennsylvania Sta ...  Show more

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. How ...

In 1960, FDA scientist Frances Oldham Kelsey is tasked with approving an application for a mild sedative to be sold in America. The drug is popular across Europe and is touted to be free of side effects, so this should be a routine job. But something doesn't sit right with France ...  Show more

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ...  Show more

Ketamine was designed as an anaesthetic but its use as a recreational drug is growing fast, particularly among young people. In the UK, it’s doubled in less than ten years but it can cause serious side effects. The supply chain for the drug starts with pharmaceutical manufacturer ...  Show more